معرفی
Roslyn Bill is a Professor at Aston University, UK, leading the Aston Institute for Membrane Excellence (AIME). She holds roles as Director of AIME, Chief Scientific Officer at Estuar Pharmaceuticals, and the 50th Anniversary Professor of Biotechnology in the College of Health & Life Sciences. Her research focuses on membrane proteins, particularly aquaporins, with emphasis on their regulation and therapeutic applications in neurological disorders. Bill leads a multi-disciplinary team funded by a £10M grant from Research England. She is an ERC Advanced Grantee and has coordinated EU projects like E-MeP and EDICT.
Education:
- DPhil in Bio-Organic Chemistry, University of Oxford (1995)
- BA (Hons) 1st Class in Chemistry, University of Oxford (1990)
Research Interests:
- Membrane protein structure-function relationships
- Aquaporin regulation and glymphatic flow
- Drug discovery targeting aquaporins
- Biomembrane engineering and protein purification
Publications Trends: Recent articles emphasize aquaporin pharmacology, tetraspanin classification, and glymphatic system mechanisms. Key themes include drug development for CNS edema, structural biology of membrane proteins, and assay innovations for lipid analysis.
Awards & Recognition:
- ERC Advanced Grant (2023)
- Aston University VC’s Research Excellence Award (2023)
- FEBS National Lecturer (2019)
- Fellowships: RSC (2013), Royal Society of Biology (2012)
Grants & Leadership:
- Chair of BBSRC Research Committee E
- Member of REF2021 Sub-Panel 8 (Chemistry)
- Coordinated EU FP6/FP7 projects
- Executive Editor of BBA-Biomembranes
Labs & Initiatives:
- Aston Membrane Proteins and Lipids (AMPL)
- AIME: £10M Expanding Excellence in England programme
- Spin-outs: Estuar Pharmaceuticals
